Actively Recruiting

All Genders
ID04046796

Genetic Causes of Discrepant Clinic in Monogenic Twins

Led by University Hospital Tuebingen · Updated on 2025-03-30

50

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying twins where one twin has a rare, unexplained disease and the other is healthy. This observational molecular-genetic study aims to identify new genetic causes behind these unclear diagnoses using advanced omics technologies and re-analysis of existing data. The study focuses on improving diagnosis for these twins with suspected genetic conditions. The study involves collecting blood samples for genetic testing from both twins in each pair. One twin is affected by the rare disease, while the other remains healthy. Data from genetic analyses and clinical observations will be shared within the University Hospital Tfcbingen and with external collaborators to enhance understanding of these diseases. Participants will undergo blood sampling for genetic diagnostics and have their clinical information collected as part of routine care. Researchers will measure the number of new candidate genes, putative disease causes, and confirmed diagnoses discovered during the study. The total duration and detailed follow-up plans are based on standard clinical care and data sharing agreements, with a focus on improving diagnostic outcomes for rare genetic diseases in twins.

CONDITIONS

Brief Title

Genetic Causes of Discrepant Clinic in Monogenic Twins

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Twin pair monozygotic clinically (phenotypic) discordant twins
  • Unclear diagnosis
  • Suspected (mono-)genetic cause of the disease in one twin
Not Eligible

You will not qualify if you...

  • Missing informed consent of both twin or legal representative
  • No distinct phenotype

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - 1 day

Participants undergo blood collection for genetic diagnostic to identify candidate genes and potential molecular causes of their condition.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

University Hospital Tübingen

Tübingen, Germany, 72076

Actively Recruiting

Loading map...

Research Team

J

Jeannette Hübener-Schmid, Dr.

A

Andreas Dufke, PD Dr.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Multi-Site Leukopak Repository Providing Annotated Biospec...

Rare Diseases

Actively Recruiting

1 location

Acute Myeloid Leukemia at Initial Diagnosis and/or Relapse i...

Acute Myeloid Leukemia

Actively Recruiting

28 locations

Aswan Heart Centre - Ballana Heart Study

Genetic Predisposition to Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here